Companies whose shares are expected to see active trading in Thursday’s session are NYSE Euronext (NYSE:NYX), Bed Bath & Beyond Inc. (NASDAQ:BBBY), Amicus Therapeutics, Inc. (NASDAQ:FOLD), Arris Group, Inc. (NASDAQ:ARRS), Vivus, Inc. (NASDAQ:VVUS) and Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).

stocks to watch

NYSE Euronext (NYSE:NYX): IntercontinentalExchange Inc. has agreed to acquire its rival NYSE Euronext (NYSE:NYX) for about $8.2 billion. ICE offered $33 per share of NYSE Euronext, a 37 percent premium over its closing price on Wednesday. NYX closed Wednesday at $24.05, but soared 36.80 percent to $32.90 in early trading.

Bed Bath & Beyond Inc. (NASDAQ:BBBY): The retailer issued disappointing forecasts for the fourth quarter and full year. BBBY expects Q4 earnings of $1.60 to $1.67 per share, and full-year earnings of $4.48 to $4.54 per share. The company’s board has also approved a $2.5 billion share buyback program. Shares plunged 6.07 percent to $56.57 in early trading.

Amicus Therapeutics, Inc. (NASDAQ:FOLD): The pharmaceutical company’s shares tumbled after it disclosed late Wednesday that its lead drug to improve kidney response in Fabry disease failed to meet its goal. The company’s shares closed Wednesday at $5.77, but plunged 45 percent to $3.18 in early market trading.

Arris Group, Inc. (NASDAQ:ARRS): The cable equipment maker is acquiring Motorola Mobility’s set-top box unit from Google Inc. (NASDAQ:GOOG)  for $2.35 billion in a stock and cash deal. Google Inc (NASDAQ:GOOG) acquired Motorola Mobility in May, and has been looking for a suitor for its set-top box business for months. Arris Group, Inc. (NASDAQ:ARRS) shares were up 5 percent at $15.27 in early trading.

Vivus, Inc. (NASDAQ:VVUS): The company announced that Express Scripts Holdings Company (NASDAQ:ESRX) will now cover its obesity drug Qsymia. Vivus sales have been hurt due to lack of reimbursement options. Vivus, Inc. (NASDAQ:VVUS) shares jumped 5.12 percent to $14.35.

Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX): The struggling electronic-health records firm announced that its longtime chief executive officer, Glen Tullman, will be replaced by board member Paul Black. Shares were down 16.39 percent to $8.91 in early trading.